Medical Cannabis for Menopause: A Guide for UK Women

Introduction

Menopause affects every woman, yet for many the transition brings symptoms severe enough to significantly disrupt daily life. Hot flushes, night sweats, sleep disturbance, anxiety, joint pain, and mood changes are among the most commonly reported complaints — and for a substantial proportion of women, conventional treatments such as hormone replacement therapy (HRT) are either ineffective, contraindicated, or simply not desired.

Against this backdrop, a growing number of UK women are exploring medical cannabis as a tool for managing menopausal symptoms. A 2026 survey by Releaf, one of the UK's largest medical cannabis clinics, found that 95.4% of women patients reported effective treatment outcomes, with sleep and anxiety among the most improved domains. This guide explains the evidence, eligibility, and how to access a prescription in the UK.

The Menopause Symptom Burden

The most common symptoms of perimenopause and menopause include:

• Vasomotor symptoms — hot flushes and night sweats, affecting up to 80% of women

• Sleep disturbance — insomnia and disrupted sleep architecture

• Psychological symptoms — anxiety, low mood, irritability, and brain fog

• Musculoskeletal pain — joint aches, reduced bone density

• Genitourinary symptoms — vaginal dryness, urinary urgency

For women who cannot or choose not to use HRT — including those with a history of hormone-sensitive cancers, blood clots, or cardiovascular disease — the treatment options are limited. This is where medical cannabis is attracting increasing clinical interest.

How Cannabis May Help

The endocannabinoid system (ECS) is widely distributed throughout the body and plays a regulatory role in thermoregulation, mood, sleep, pain perception, and inflammation — all of which are disrupted during menopause. Oestrogen decline during menopause is associated with reduced endocannabinoid tone, which may partly explain why some women experience such significant symptom burden.

Cannabinoids, particularly CBD and THC, interact with the ECS and may help to:

• Reduce hot flush frequency and severity — via modulation of the hypothalamic thermoregulatory centre

• Improve sleep quality — THC has well-documented sleep-promoting effects, and CBD may reduce anxiety-driven sleep disruption

• Alleviate anxiety and low mood — CBD has demonstrated anxiolytic properties in multiple clinical studies

• Reduce joint and musculoskeletal pain — both CBD and THC have anti-inflammatory and analgesic properties

In October 2025, Alternaleaf became the first UK clinic to launch a dedicated women's health cannabis service, specifically addressing endometriosis, perimenopause, and chronic pain in women — a recognition of the growing clinical need in this area.

Who May Be Eligible?

Medical cannabis for menopause-related symptoms is typically considered when:

• The patient is experiencing moderate to severe symptoms that are significantly affecting quality of life

• HRT is contraindicated, has been tried and failed, or is not desired by the patient

• Other pharmacological options (such as SSRIs for vasomotor symptoms, or gabapentin for pain) have been inadequate

A specialist clinician will assess your full medical history, current medications, and symptom profile before making a prescribing decision.

What Products Are Typically Used?

For menopause, UK clinicians most commonly prescribe:

• CBD-dominant oils — for anxiety, mood, and mild pain, with minimal psychoactive effect

• Balanced CBD:THC oils or capsules — for sleep disturbance combined with anxiety or pain

• Low-dose THC products — for more severe sleep disruption or vasomotor symptoms

The dose is always started low and titrated gradually under clinical supervision.

How to Access a Prescription

CPGUK can help you understand whether medical cannabis may be appropriate for your menopause symptoms and guide you through the process of accessing a specialist consultation. Our service is free, confidential, and available to women across the UK.

Important Considerations

Medical cannabis is not a replacement for HRT in women for whom HRT is appropriate and desired. It does not address the underlying hormonal changes of menopause. It should be considered as a complementary or alternative option for symptom management, particularly for women who cannot or choose not to use HRT.

As with all medical cannabis prescriptions in the UK, costs are borne privately, typically ranging from £150 to £350 per month depending on the product.

Conclusion

Medical cannabis offers a promising option for UK women managing difficult menopausal symptoms, particularly those for whom HRT is not suitable. The evidence base is growing, dedicated women's health cannabis services are now available in the UK, and patient-reported outcomes are broadly positive. CPGUK is here to help you navigate your options.